programmed computer chips, could net genetically-engineered "vaccines" and doctored viruses that target prostate cancer cells for search-and-destroy missions. In any case, physicians soon may have therapies that derail the disease long before Huggins's therapy is necessary. With science shedding new light on this old threat, their patients may bask in the reality, not just the hope, of a cure.